Literature DB >> 24759156

Onyx embolization of dural arteriovenous fistulas of the cavernous sinus through the superior pharyngeal branch of the ascending pharyngeal artery.

Guglielmo Pero1, Luca Quilici, Mariangela Piano, Luca Valvassori, Edoardo Boccardi.   

Abstract

We report three cases of dural arteriovenous fistula (DAVF) of the cavernous sinus treated by Onyx injection through the superior pharyngeal branch of the ascending pharyngeal artery. The treatment of choice of DAVFs of the cavernous sinus is endovascular, and it is preferentially done via transvenous occlusion of the cavernous sinus. The cavernous sinus can be reached through either the inferior petrosal sinus or the superior ophthalmic vein. When these venous routes are occluded, the first attempt is to pass through the occluded inferior petrosal sinus, but sometimes this attempt can fail. In some cases there are small transosseous feeders to the fistula arising from the superior pharyngeal branch of the ascending pharyngeal artery. When all of the more conventional approaches are unattainable, this route can be attempted. In our experience, it allowed safe and rapid occlusion of the fistula.

Entities:  

Keywords:  Fistula; Intervention; Liquid Embolic Material; Meninges; Navigation

Mesh:

Substances:

Year:  2014        PMID: 24759156      PMCID: PMC4009911          DOI: 10.1136/bcr-2013-011067

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Transcortical venous approach for direct embolization of a cavernous sinus dural arteriovenous fistula: technical case report.

Authors:  Navjot Chaudhary; Stephen P Lownie; Miguel Bussière; David M Pelz; David Nicolle
Journal:  Neurosurgery       Date:  2012-06       Impact factor: 4.654

2.  Superior petrosal sinus catheterization for transvenous embolization of a dural carotid cavernous sinus fistula.

Authors:  Charbel Mounayer; Michel Piotin; Laurent Spelle; Jacques Moret
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

3.  The treatment of a dural carotid cavernous fistula (CCF) using Onyx via a transorbital approach: a technical note.

Authors:  Homoyoon Mehrzad; Kushnood Alam; Adam Rennie
Journal:  Neuroradiology       Date:  2010-11-24       Impact factor: 2.804

4.  Transarterial and transvenous embolization for cavernous sinus dural arteriovenous fistulae.

Authors:  J Zhang; X Lv; C Jiang; Y Li; X Yang; Z Wu
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

5.  Curative embolization with Onyx of dural arteriovenous fistulas with cortical venous drainage.

Authors:  W J van Rooij; M Sluzewski
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

6.  Therapeutic management of intracranial dural arteriovenous shunts with leptomeningeal venous drainage: report of 53 consecutive patients with emphasis on transarterial embolization with acrylic glue.

Authors:  Pierre Guedin; Stephan Gaillard; Anne Boulin; Stephanie Condette-Auliac; Frederic Bourdain; Stephanie Guieu; Michel Dupuy; Georges Rodesch
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

7.  Transorbital endovascular embolization of dural carotid-cavernous fistula: access to cavernous sinus through direct puncture: case examples and technical report.

Authors:  Shervin R Dashti; David Fiorella; Robert F Spetzler; Felipe C Albuquerque; Cameron G McDougall
Journal:  Neurosurgery       Date:  2011-03       Impact factor: 4.654

8.  Superficial temporal vein: route to embolization of cavernous dural arteriovenous fistula.

Authors:  Jasmeet Singh; P Pearse Morris
Journal:  J Neuroimaging       Date:  2010-04-13       Impact factor: 2.486

9.  Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage: new management using Onyx.

Authors:  C Cognard; A C Januel; N A Silva; P Tall
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

10.  Successful transarterial embolization of a Barrow type D dural carotid-cavernous fistula with ethylene vinyl alcohol copolymer (Onyx).

Authors:  Dheeraj Gandhi; Sameer A Ansari; Wayne T Cornblath
Journal:  J Neuroophthalmol       Date:  2009-03       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.